84 related articles for article (PubMed ID: 18322598)
21. Molecular analysis of human influenza virus in Tehran, Iran.
Soltani Z; Hosseini M; Shahidi M; Hedayati M; Kheiri MT
Intervirology; 2009; 52(2):63-7. PubMed ID: 19401630
[TBL] [Abstract][Full Text] [Related]
22. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
[TBL] [Abstract][Full Text] [Related]
23. Fecal detection of influenza A virus in patients with concurrent respiratory and gastrointestinal symptoms.
Chan MC; Lee N; Chan PK; Leung TF; Sung JJ
J Clin Virol; 2009 Jul; 45(3):208-11. PubMed ID: 19540157
[TBL] [Abstract][Full Text] [Related]
24. Design and Development of a Quantitative TaqMan Real-Time PCR Assay for Evaluation of HIV-1 (group M) Viral Load in Plasma Using Armored RNA Standard.
Gholami M; Baesi K; Ravanshad M; Samiee SM; Rouzbahani NH; Mohraz M
Clin Lab; 2018 Jun; 64(6):955-963. PubMed ID: 29945309
[TBL] [Abstract][Full Text] [Related]
25. [Construction of plasmid expression vector for specific peptide of the rubella virus E1 gene].
Cao J; Huang YF; Gao J; Wang HY; Lu JC
Zhonghua Nan Ke Xue; 2009 Apr; 15(4):318-21. PubMed ID: 19472904
[TBL] [Abstract][Full Text] [Related]
26. [Expression of influenza A3 virus (H3N2) M2 gene in vaccinia virus Tiantan strain].
Wang WL; Huang BY; Deng Y; Wang XP; Tan WJ; Ruan L
Bing Du Xue Bao; 2007 Sep; 23(5):377-83. PubMed ID: 17969855
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Nanogen MGB Alert Detection Reagents in a multiplex real-time PCR for influenza virus types A and B and respiratory syncytial virus.
Hymas WC; Hillyard DR
J Virol Methods; 2009 Mar; 156(1-2):124-8. PubMed ID: 19061916
[TBL] [Abstract][Full Text] [Related]
28. Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays.
Suwannakarn K; Payungporn S; Chieochansin T; Samransamruajkit R; Amonsin A; Songserm T; Chaisingh A; Chamnanpood P; Chutinimitkul S; Theamboonlers A; Poovorawan Y
J Virol Methods; 2008 Sep; 152(1-2):25-31. PubMed ID: 18598722
[TBL] [Abstract][Full Text] [Related]
29. Identification of a human monoclonal Fab with neutralizing activity against H3N2 influenza A strain from a newly constructed human Fab library.
Shibuya T; Yamashiro T; Masaike Y; Ohuchi M; Uechi G; Nishizono A
Microbiol Immunol; 2008 Mar; 52(3):162-70. PubMed ID: 18402598
[TBL] [Abstract][Full Text] [Related]
30. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
Schmidtke M; Bauer K; Ludwig N; Wutzler P
Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
[No Abstract] [Full Text] [Related]
31. [Construction and Expression of RNase-Resisting His-Tagged Virus-Like Particles Containing FluA/B mRNA].
Zhang J; Xue X; Xu H; Zhu K; Chen X; Zhang J; Zhang Q; Lin Y
Bing Du Xue Bao; 2015 Nov; 31(6):629-33. PubMed ID: 26951007
[TBL] [Abstract][Full Text] [Related]
32. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
33. Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006.
Tang JW; Ngai KL; Wong JC; Lam WY; Chan PK
J Med Virol; 2008 May; 80(5):895-901. PubMed ID: 18360910
[TBL] [Abstract][Full Text] [Related]
34. Sequencing and mutational analysis of the non-coding regions of influenza A virus.
Wang L; Lee CW
Vet Microbiol; 2009 Mar; 135(3-4):239-47. PubMed ID: 18986781
[TBL] [Abstract][Full Text] [Related]
35. [Preparation and Characterization of Recombinant HEV RNA-loaded MS2 Bacteriophage Capsid by Armored RNA Technology].
Liu Y; Wang S; Zhou T; Gao S
Bing Du Xue Bao; 2016 Sep; 32(5):538-44. PubMed ID: 30001574
[TBL] [Abstract][Full Text] [Related]
36. Armored long RNA controls or standards for branched DNA assay for detection of human immunodeficiency virus type 1.
Zhan S; Li J; Xu R; Wang L; Zhang K; Zhang R
J Clin Microbiol; 2009 Aug; 47(8):2571-6. PubMed ID: 19494069
[TBL] [Abstract][Full Text] [Related]
37. Preparation and Evaluation of Ribonuclease-Resistant Viral HIV RNA Standards Based on Armored RNA Technology.
Gholami M; Ravanshad M; Baesi K; Samiee SM; Hosseini Rozbahani N; Mohraz M
Iran Biomed J; 2018 Nov; 22(6):394-400. PubMed ID: 29776310
[TBL] [Abstract][Full Text] [Related]
38. Molecular evolution of HA1 in influenza A (H3N2) viruses isolated in Japan from 1989 to 2006.
Saitoh M; Kimura H; Kozawa K; Shoji A
Intervirology; 2008; 51(6):377-84. PubMed ID: 19158442
[TBL] [Abstract][Full Text] [Related]
39. RNA interference of avian influenza virus H5N1 by inhibiting viral mRNA with siRNA expression plasmids.
Zhou K; He H; Wu Y; Duan M
J Biotechnol; 2008 Jun; 135(2):140-4. PubMed ID: 18456361
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous one-tube full-length amplification of the NA, NP, M, and NS genes of influenza A viruses for reverse genetics.
Kreibich A; Stech J; Mettenleiter TC; Stech O
J Virol Methods; 2009 Aug; 159(2):308-10. PubMed ID: 19406155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
